The startup provides portable drug testing services that utilize patented noninvasive sample collection technology combined with validated laboratory detection methods for rapid and quantitative screening. This enables businesses to conduct on-site drug testing efficiently, ensuring workplace safety and compliance without the need for traditional lab visits.
Funding
$4.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current rapid drug testing methods lack the specificity to differentiate between psychoactive THC and other non-psychoactive cannabinoids like CBD, leading to inaccurate results. Traditional lab-based tests are more precise but require a lengthy turnaround time, delaying critical workplace decisions. Employers need a way to accurately and quickly detect workday marijuana use without infringing on employees' legal off-duty activities.
Solution
Buzzkill Labs offers ToxiTrace™, a fully-automated, on-site drug testing system that uses lab-standard chromatography to isolate and identify psychoactive THC in oral fluid samples. This "lab-in-a-box" solution filters out metabolites of THC and non-psychoactive cannabinoids, providing a real-time reading on marijuana use within approximately 20 minutes. By focusing specifically on psychoactive THC, ToxiTrace™ enables employers to identify recent marijuana consumption during work hours, distinguishing it from past use or the use of legal CBD products. The system uses a 2mL oral fluid collection, a sample type recognized by the federal government, and can detect psychoactive THC from all forms of marijuana, including edibles.
Target Audience
The primary target audience includes occupational health clinics, drug testing centers, and employers seeking a reliable method for workday marijuana use detection.
Features
- Fully-automated, on-site testing system using lab-standard chromatography
- Specific detection of psychoactive THC, differentiating it from CBD and other non-psychoactive cannabinoids
- Rapid results in approximately 20 minutes
- Uses 2mL oral fluid samples, a federally recognized sample type
- Detects psychoactive THC from all forms of marijuana consumption, including edibles
- Provides real-time readings on marijuana use